SARS-CoV-2 Antibody Seroprevalence in Patients With Cancer on Systemic Antineoplastic Treatment in the First Wave of the COVID-19 Pandemic in Portugal
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.